{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:01:49Z","timestamp":1774551709437,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"am","delay-in-days":406,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.2515\/therapie\/2015054","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T08:38:01Z","timestamp":1445330281000},"page":"S51-S57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["Analyse des seringues usag\u00e9es\u00a0: un reflet de la consommation de substances psychoactives par les usagers de drogues par voie intraveineuse\u00a0?"],"prefix":"10.1016","volume":"78","author":[{"given":"Sandra","family":"Nordmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Nefau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Duplessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Catusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Frauger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2015054_bib0135","series-title":"Drogues et conduites addictives\u00a0: comprendre savoir aider. \u00c9dition\u00a02014","year":"2015"},{"issue":"5","key":"10.2515\/therapie\/2015054_bib0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2515\/therapie\/2012064","article-title":"Les CAARUD, lieux privil\u00e9gi\u00e9s d\u2019\u00e9mergence de signaux pour l\u2019addictovigilance","volume":"67","author":"Moracchini","year":"2012","journal-title":"Therapie"},{"issue":"5","key":"10.2515\/therapie\/2015054_bib0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/00015550510033192","article-title":"Cutaneous complications of direct intra-arterial injections in drug addicts","volume":"85","author":"Del Giudice","year":"2005","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.2515\/therapie\/2015054_bib0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.revmed.2009.10.433","article-title":"Complications infectieuses induites par le m\u00e9susage de la bupr\u00e9norphine haut dosage (Subutex\u00ae)\u00a0: analyse r\u00e9trospective de 42\u00a0observations","volume":"31","author":"Grau","year":"2010","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.2515\/therapie\/2015054_bib0155","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2515\/therapie\/2008063","article-title":"Isch\u00e9mie digitale apr\u00e8s injection d\u2019un comprim\u00e9 pil\u00e9 de zolpidem, am\u00e9lioration tardive par l\u2019iloprost","volume":"63","author":"Boucher","year":"2008","journal-title":"Therapie"},{"issue":"12","key":"10.2515\/therapie\/2015054_bib0160","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1056\/NEJMicm050711","article-title":"Images in clinical medicine. Talc retinopathy","volume":"354","author":"El-Jabali","year":"2006","journal-title":"N Engl J Med"},{"issue":"1\u20133","key":"10.2515\/therapie\/2015054_bib0165","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.forsciint.2009.12.066","article-title":"Widespread pulmonary granulomatosis following long time intravenous drug abuse \u2013 a case report","volume":"197","author":"Dettmeyer","year":"2010","journal-title":"Forensic Sci Int"},{"issue":"12","key":"10.2515\/therapie\/2015054_bib0170","doi-asserted-by":"crossref","first-page":"e113991","DOI":"10.1371\/journal.pone.0113991","article-title":"Crushed and injected buprenorphine tablets: characteristics of princeps and generic solutions","volume":"9","author":"Bouqui\u00e9","year":"2014","journal-title":"Plos One"},{"issue":"5","key":"10.2515\/therapie\/2015054_bib0175","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/bjd.13503","article-title":"Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French survey","volume":"172","author":"Wainstein","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.2515\/therapie\/2015054_bib0180","first-page":"244","article-title":"Estimation de la s\u00e9ropr\u00e9valence du VIH et du VHC et profils des usagers de drogues en France, \u00e9tude InVS-ANRS Coquelicot, 2004","volume":"33","author":"Jauffret-Roustide","year":"2006","journal-title":"Bull Epidemiol Hebd"},{"key":"10.2515\/therapie\/2015054_bib0185","series-title":"R\u00e9duction des risques infectieux chez les usagers de drogues. Expertise collective. \u00c9dition\u00a02010","year":"2015"},{"issue":"4","key":"10.2515\/therapie\/2015054_bib0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.drugpo.2014.09.010","article-title":"Drug analysis of residual content of used syringes: a new approach for improving knowledge of injected drugs and drug user practices","volume":"26","author":"N\u00e9fau","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.2515\/therapie\/2015054_bib0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/02791072.2014.959215","article-title":"Levamisole-adulterated cocaine: what about in European countries?","volume":"46","author":"Eiden","year":"2014","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"10.2515\/therapie\/2015054_bib0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/15563650.2012.665455","article-title":"Levamisole in cocaine: unexpected news from an old acquaintance","volume":"50","author":"Larocque","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"10.2515\/therapie\/2015054_bib0205","series-title":"\u00c9tude des pratiques d\u2019injection intraveineuse et autres d\u00e9tournements du m\u00e9thylph\u00e9nidate (r\u00e9gion Paca-Corse). Le courrier des addictions no\u00a04","author":"Frauger","year":"2011"},{"issue":"2","key":"10.2515\/therapie\/2015054_bib0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2515\/therapie\/2015012","article-title":"Un exemple d\u2019investigation d\u2019un ph\u00e9nom\u00e8ne \u00ab\u00a0\u00e9mergent\u00a0\u00bb en addictovigilance\u00a0: \u00e0 propos du m\u00e9thylph\u00e9nidate","volume":"70","author":"Micallef","year":"2015","journal-title":"Therapie"},{"issue":"6","key":"10.2515\/therapie\/2015054_bib0215","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/fcp.12024","article-title":"OPPIDUM surveillance program: 20\u00a0years of information on drug abuse in France","volume":"27","author":"Frauger","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"10.2515\/therapie\/2015054_bib0220","series-title":"R\u00e9sultats ENa-CAARUD 2010, profils et pratiques des usagers","author":"Cadet-Ta\u00efrou","year":"2012"},{"issue":"6","key":"10.2515\/therapie\/2015054_bib0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2515\/therapie\/2010077","article-title":"La m\u00e9ph\u00e9drone\u00a0: une designer drug d\u2019usage r\u00e9cent en France","volume":"65","author":"Debruyne","year":"2010","journal-title":"Therapie"},{"key":"10.2515\/therapie\/2015054_bib0230","series-title":"SLAM, premi\u00e8re enqu\u00eate qualitative en France","author":"Foureur","year":"2013"},{"issue":"18","key":"10.2515\/therapie\/2015054_bib0235","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1097\/QAD.0000000000000029","article-title":"Viral and bacterial risks associated with mephedrone abuse in HIV-infected men who have sex with men","volume":"27","author":"Peyri\u00e8re","year":"2013","journal-title":"AIDS"},{"key":"10.2515\/therapie\/2015054_bib0240","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European Union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"Eur Addict Res"},{"issue":"4","key":"10.2515\/therapie\/2015054_bib0245","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000356812","article-title":"A european community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions","volume":"20","author":"Lapeyre-Mestre","year":"2014","journal-title":"Eur Addict Res"},{"key":"10.2515\/therapie\/2015054_bib0250","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.scitotenv.2013.05.038","article-title":"Presence of illicit drugs and metabolites in influents and effluents of 25\u00a0sewage water treatment plants and map of drug consumption in France","volume":"461\u2013462","author":"Nefau","year":"2013","journal-title":"Sci Total Environ"},{"key":"10.2515\/therapie\/2015054_bib0255","first-page":"89","article-title":"Doctor shopping reveals geographical variations in opioid abuse","volume":"16","author":"Nordmann","year":"2013","journal-title":"Pain Phys"},{"issue":"2","key":"10.2515\/therapie\/2015054_bib0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2515\/therapie\/2015009","article-title":"Comment identifier un signal en addictovigilance\u00a0?","volume":"70","author":"Jouanjus","year":"2015","journal-title":"Therapie"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T18:26:42Z","timestamp":1718735202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059571630049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S004059571630049X"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2015054","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyse des seringues usag\u00e9es\u00a0: un reflet de la consommation de substances psychoactives par les usagers de drogues par voie intraveineuse\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2515\/therapie\/2015054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}